Online citations, reference lists, and bibliographies.
← Back to Search

A Glycotherapeutic Approach To Functionalize Biomaterials-based Systems

Anuja Gadekar, S. Bhowmick, A. Pandit
Published 2020 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Authors would like to acknowledge the Science Foundation Ireland (SFI) and the European Regional Development Fund (Grant Number 13/RC/2073) for financial assistance. A.G. is supported through a research grant (16/ENM-ERA/3456) received under SFI ERA-NET Horizon 2020 program. S.B is supported through Horizon 2020, Marie Sklodowska-Curie Individual Fellowship-2017 (H2020-MSCA-IF-2017; Grant Number 797855).
This paper references
10.1039/c6cc08978j
Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity.
H. Wang (2017)
10.1038/35001095
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
P. Kitov (2000)
10.1080/10611860500525370
Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes
M. Garg (2006)
10.1515/BC.2001.022
O-Glycosylation of the Mucin Type
F. G. Hanisch (2001)
10.1021/JA031698U
Glycodendriproteins: a synthetic glycoprotein mimic enzyme with branched sugar-display potently inhibits bacterial aggregation.
P. M. Rendle (2004)
10.1016/J.BIOMATERIALS.2006.09.014
Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes.
K. M. Kamruzzaman Selim (2007)
10.1146/annurev-nutr-071812-161240
O-GlcNAc cycling: a link between metabolism and chronic disease.
Michelle R. Bond (2013)
10.1016/S0166-3542(02)00052-9
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.
S. Aquaro (2002)
10.1016/j.molimm.2012.09.012
Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells.
Juan J. García‐Vallejo (2013)
A membrane-associated form of C-reactive protein is the galactose-specific particle receptor on rat liver macrophages.
G. Kempka (1990)
10.1016/0092-8674(91)90174-W
Selectins: A family of adhesion receptors
M. Bevilacqua (1991)
10.1007/s11095-016-2081-3
Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice
Rinku Dutta (2016)
10.1021/jacs.5b00592
Probing cell-surface carbohydrate binding proteins with dual-modal glycan-conjugated nanoparticles.
Sungjin Park (2015)
10.1146/ANNUREV.CELLBIO.22.022206.160206
Cellulose synthesis in higher plants.
C. Somerville (2006)
10.1016/J.ABB.2004.04.019
IL-4 modulates transcriptional control of the mannose receptor in mouse FSDC dendritic cells.
B. Egan (2004)
10.1073/PNAS.74.7.3011
Glycolipid-bound sialic acid in serum: increased levels in mice and humans bearing mammary carcinomas.
T. M. Kloppel (1977)
10.1006/BBRC.1998.9602
Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
S. Kawakami (1998)
10.1002/anie.201300068
Sequence-controlled multi-block glycopolymers to inhibit DC-SIGN-gp120 binding.
Q. Zhang (2013)
10.1126/science.1178746
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
L. Walker (2009)
10.1166/JNN.2006.445
Bioadhesive mannosylated nanoparticles for oral drug delivery.
Hesham H. Salman (2006)
10.1016/J.COLSURFA.2015.04.035
Glycopolymer modified magnetic mesoporous silica nanoparticles for MR imaging and targeted drug delivery
Jinxia An (2015)
10.1021/NL035010N
Superparamagnetic Fe2O3 Beads−CdSe/ZnS Quantum Dots Core−Shell Nanocomposite Particles for Cell Separation
D. Wang (2004)
10.1021/ja909062q
Tyrosine bioconjugation through aqueous ene-type reactions: a click-like reaction for tyrosine.
Hitoshi Ban (2010)
10.1124/jpet.105.099499
The Antiproliferative Drug Doxorubicin Inhibits Liver Fibrosis in Bile Duct-Ligated Rats and Can Be Selectively Delivered to Hepatic Stellate Cells in Vivo
R. Greupink (2006)
10.1038/nchembio.96
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.
Scott A. Yuzwa (2008)
10.1021/mp2005033
Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.
Meredith A. Mintzer (2012)
10.1016/j.ab.2009.05.036
Functional gold nanoparticles for studying the interaction of lectin with glycosyl complex on living cellular surfaces.
Jine Wang (2009)
10.1021/JA027538K
Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesis.
M. Hewitt (2002)
10.1021/JM0110237
Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional alpha 2,3/alpha 2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake.
C. Unverzagt (2002)
10.1016/S0092-8674(02)01114-5
Regulation of Notch Signaling by O-Linked Fucose
T. Okajima (2002)
10.1155/2017/7045630
Mannose-Binding Lectin: Biologic Characteristics and Role in the Susceptibility to Infections and Ischemia-Reperfusion Related Injury in Critically Ill Neonates
C. Auriti (2017)
10.1016/j.bmc.2018.02.028
Site-selective installation of an electrophilic handle on proteins for bioconjugation.
Bernadette Lee (2018)
10.4049/jimmunol.178.8.4975
Mannose Receptor Expression and Function Define a New Population of Murine Dendritic Cells1
E. Mckenzie (2007)
10.1016/j.bcp.2011.05.018
Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapy.
C. Jandus (2011)
10.1016/j.chembiol.2009.08.002
Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions.
Z. Shriver (2009)
10.1021/JO035125B
Blockwise approach to fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a: convergent Synthesis of a decasaccharide representative of a dimer of the branched repeating unit.
F. Bélot (2004)
10.1039/c5sc04392a
Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides
Shayli Varasteh Moradi (2016)
10.1097/QAD.0b013e32834e1567
A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models
Angela Berzi (2012)
10.1016/j.talanta.2006.05.064
Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles.
Jiaofeng Peng (2007)
10.1021/ja709993p
Neuroactive chondroitin sulfate glycomimetics.
Manish Rawat (2008)
10.1016/0046-8177(90)90250-9
Cancer-associated carbohydrates identified by monoclonal antibodies.
S. Sell (1990)
10.1016/j.ijpharm.2008.03.039
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Aihua Lin (2008)
10.1038/nature05819
Synthesis and medical applications of oligosaccharides
P. Seeberger (2007)
10.1016/J.NUCMEDBIO.2006.03.005
Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan.
E. Kim (2006)
10.1016/j.jconrel.2015.06.033
MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.
M. Boks (2015)
10.1016/S0168-3659(01)00555-7
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes.
K. Sagara (2002)
10.1016/j.ijpharm.2013.03.019
Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Caiyun Li (2013)
10.1038/nrd2804
Glycosylation as a strategy to improve antibody-based therapeutics
R. Jefferis (2009)
10.1002/anie.201500286
Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
O. Vaillant (2015)
10.1039/c2cs35424a
Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate-protein interactions.
Álvaro Martínez (2013)
10.1023/A:1021433206081
Targeting Efficiency of Galactosylated Liposomes to Hepatocytes in Vivo: Effect of Lipid Composition
A. Murao (2004)
10.1211/jpp.58.6.0003
Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells
K. White (2006)
10.1186/gb-2001-2-5-reviews0004
Characterizing glycosylation pathways
K. Yarema (2001)
10.1038/mt.2015.215
Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response
A. Garu (2016)
10.4049/jimmunol.176.3.1686
Characterization of Functional Oligosaccharide Mimics of the Shigella flexneri Serotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine1
A. Phalipon (2006)
10.1021/cb300345e
Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.
D. Bundle (2012)
10.1073/PNAS.76.7.3198
Structure of the antithrombin-binding site in heparin.
U. Lindahl (1979)
10.1021/mp400400j
Delivery of chemically glycosylated cytochrome c immobilized in mesoporous silica nanoparticles induces apoptosis in HeLa cancer cells.
Jessica Méndez (2014)
10.1007/s11095-006-9025-2
Mannose-6-Phosphate/Insulin-Like Growth Factor-II Receptors may Represent a Target for the Selective Delivery of Mycophenolic Acid to Fibrogenic Cells
R. Greupink (2006)
10.1021/ja801052g
Sialoside analogue arrays for rapid identification of high affinity siglec ligands.
O. Blixt (2008)
10.1002/ana.20162
MR molecular imaging of early endothelial activation in focal ischemia
P. Barber (2004)
10.1021/JA027184X
Influencing receptor-ligand binding mechanisms with multivalent ligand architecture.
J. Gestwicki (2002)
10.1182/blood-2009-12-257386
In vivo targeting of B-cell lymphoma with glycan ligands of CD22.
Weihsu C Chen (2010)
10.1016/0092-8674(91)90287-9
A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAcβ1, 4GlcNAcβ1,2Manα that mediates rapid clearance of lutropin
D. Fiete (1991)
10.1039/c0ob00389a
Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands.
D. Deniaud (2011)
10.1038/84643
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M. Skobe (2001)
Persistence of antibodies in human subjects injected with pneumococcal polysaccharides.
M. Heidelberger (1950)
10.1084/JEM.82.6.445
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
C. Macleod (1945)
10.1021/jacs.7b10702
Chemoselective Installation of Amine Bonds on Proteins through Aza-Michael Ligation
Allyson M Freedy (2017)
10.1002/ANIE.200300640
A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
M. Petitou (2004)
10.1016/j.jconrel.2014.06.001
Glycosylation-mediated targeting of carriers.
S. Kawakami (2014)
10.1038/ncomms2302
Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
Renato Ribeiro-Viana (2012)
10.1146/ANNUREV.BIOCHEM.73.011303.074043
Role of glycosylation in development.
R. Haltiwanger (2004)
10.1016/j.jconrel.2015.01.040
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Cynthia M. Fehres (2015)
10.1093/JAC/31.1.151
Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin.
R. Sett (1993)
10.1126/SCIENCE.1095209
A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b
V. Verez-Bencomo (2004)
10.1038/nm0106-75
Diabetes and obesity: the twin epidemics
S. Smyth (2006)
10.1039/b819896a
Lessons learned from the contamination of heparin.
Haiying Liu (2009)
10.1038/363418A0
Rational design of potent sialidase-based inhibitors of influenza virus replication
M. Itzstein (1993)
10.1016/j.molimm.2009.09.026
Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
S. Singh (2009)
10.1016/S0378-5173(03)00128-5
Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety.
I. Kim (2003)
10.1038/nrc2761
Mucins in cancer: function, prognosis and therapy
D. Kufe (2009)
10.1152/PHYSREV.00015.2016
Leveraging Physiology for Precision Drug Delivery
Wujin Sun (2017)
10.1038/84696
Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector
D. Steinwaerder (2001)
10.1016/j.colsurfb.2007.12.014
Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity.
M. Gou (2008)
10.1038/nrg1829
Genetic medicines: treatment strategies for hereditary disorders
T. P. O’Connor (2006)
10.1155/2017/5482768
Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor
Ildefonso Alves da Silva Junior (2017)
10.1039/c8cs00495a
Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification.
F. Berti (2018)
10.1016/j.biomaterials.2013.03.074
Sentinel lymph node imaging by a fluorescently labeled DNA tetrahedron.
K. Kim (2013)
10.1126/science.1207438
Human Sperm Binding Is Mediated by the Sialyl-Lewisx Oligosaccharide on the Zona Pellucida
P. Pang (2011)
10.1039/C6RA02754G
A highly stable and biocompatible optical bioimaging nanoprobe based on carbon nanospheres
X. Liu (2016)
10.1158/1078-0432.CCR-09-0737
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
M. Cheever (2009)
10.1038/nrd2852
From carbohydrate leads to glycomimetic drugs
B. Ernst (2009)
10.1016/S0008-6215(00)81050-2
Further characterization of the antithrombin-binding sequence in heparin.
L. Thunberg (1982)
10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
Biofibres, biodegradable polymers and biocomposites: An overview
A. K. Mohanty (2000)
10.1126/science.1232552
Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity
Jin-Hyo Kim (2013)
10.1002/EJOC.201100296
Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation
L. Morelli (2011)
10.1016/j.vaccine.2010.06.026
Glycoconjugate vaccines and immune interference: A review.
R. Dagan (2010)
10.1073/PNAS.83.8.2501
Identification of the macrophage mannose receptor as a 175-kDa membrane protein.
T. Wileman (1986)
10.1016/S1389-0352(01)00062-9
Design and synthesis of glycodendrimers.
W. Turnbull (2002)
10.1021/bi800205t
Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.
R. Copeland (2008)
10.1038/nrc903
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
10.1074/jbc.274.27.19087
Mannose Polyethylenimine Conjugates for Targeted DNA Delivery into Dendritic Cells*
S. Diebold (1999)
10.1038/nchem.399
Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research.
Thomas J Boltje (2009)
10.1615/CRITREVTHERDRUGCARRIERSYST.V18.I1.10
Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.
S. Vyas (2001)
10.1021/bm300578p
Glycan-targeted virus-like nanoparticles for photodynamic therapy.
Jin-Kyu Rhee (2012)
10.1002/ANIE.200602048
Anti-carbohydrate antibodies for the detection of anthrax spores.
M. Tamborrini (2006)
10.1080/1061186X.2017.1365873
Selective induction of apoptosis in MCF7 cancer-cell by targeted liposomes functionalised with mannose-6-phosphate
Cristina Minnelli (2018)
10.1002/cbic.201200480
Synthesis of Glycopolymers by Controlled Radical Polymerization Techniques and Their Applications
Vimary Vázquez-Dorbatt (2012)
10.1021/cb200429n
Emerging technologies for making glycan-defined glycoproteins.
L. Wang (2012)
10.1021/ja00378a025
Determination of addition rates of benzenethiyl radicals to alkynes by flash photolysis. Structures of produced vinyl-type radicals
O. Ito (1982)
10.1016/J.BBAGEN.2007.09.010
Mucin-type O-glycosylation and its potential use in drug and vaccine development.
M. A. Tarp (2008)
10.1039/c2cs35420a
Glyconanoparticles as multifunctional and multimodal carbohydrate systems.
M. Marradi (2013)
10.1186/1472-6750-10-57
Moisture-induced solid state instabilities in α-chymotrypsin and their reduction through chemical glycosylation
Giselle M. Flores-Fernández (2010)
10.3390/ijms17091440
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses
P. Siafaka (2016)
10.1016/j.biomaterials.2009.03.016
Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
A. Agarwal (2009)
10.1080/10611860600965914
Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
T. Dutta (2007)
10.1002/cbic.200700266
Strong Inhibition of Cholera Toxin by Multivalent GM1 Derivatives
A. Pukin (2007)
10.1002/chem.201700745
Site‐Selective Modification of Proteins with Oxetanes
Omar Boutureira (2017)
10.1152/AJPLEGACY.1939.125.4.683
THE INHIBITION OF BLOOD CLOTTING: AN UNIDENTIFIED SUBSTANCE WHICH ACTS IN CONJUNCTION WITH HEPARIN TO PREVENT THE CONVERSION OF PROTHROMBIN INTO THROMBIN
K. Brinkhous (1939)
10.1038/nature00937
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria
L. Schofield (2002)
10.1073/pnas.1115166109
Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
Vani Lakshminarayanan (2011)
10.3109/10611869509059211
Receptor mediated glycotargeting.
M. S. Wadhwa (1995)
10.1002/cbic.200800550
The Influence of Ligand Valency on Aggregation Mechanisms for Inhibiting Bacterial Toxins
Cristina Sisu (2009)
10.1002/anie.201006327
A coordinated synthesis and conjugation strategy for the preparation of homogeneous glycoconjugate vaccine candidates.
E. Grayson (2011)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.1021/cr3003714
High-sensitivity analytical approaches for the structural characterization of glycoproteins.
W. Alley (2013)
10.3109/03639040903099744
Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages
S. Chono (2010)
10.2174/156802608785848987
Recent trends in glycodendrimer syntheses and applications.
Y. Chabre (2008)
10.1039/C4PY00339J
Thiol–ene “click” reactions and recent applications in polymer and materials synthesis: a first update
A. B. Lowe (2014)
10.1021/ja211725s
A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy.
Zhi-Hua Huang (2012)
10.1073/PNAS.78.2.1019
L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages.
V. Shepherd (1981)
10.2174/156802608785849058
Glycopeptide dendrimers for biomedical applications.
T. Darbre (2008)
10.3109/10611869708995857
Lectins for drug delivery within the oral cavity--investigation of lectin binding to oral mucosa.
P. K. Nantwi (1997)
10.3109/10611869908996849
Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver.
A. Nag (1999)
10.1021/acs.bioconjchem.6b00385
Site-Directed Glycosylation of Peptide/Protein with Homogeneous O-Linked Eukaryotic N-Glycans.
Zhigang Wu (2016)
10.1042/BJ2570651
Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells.
S. Magnusson (1989)
10.1073/PNAS.96.10.5710
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.
S. Slovin (1999)
10.1242/jcs.073643
Regulation of the Apaf-1–caspase-9 apoptosome
S. B. Bratton (2010)
10.1016/J.EJPB.2004.11.011
Polyethylenimine-based non-viral gene delivery systems.
U. Lungwitz (2005)
10.1016/0378-5173(96)04540-1
Lectins in ocular drug delivery: An investigation of lectin binding sites on the corneal and conjunctival surfaces
T. J. Nicholls (1996)
10.1016/j.jconrel.2009.07.009
Revisit the complexation of PEI and DNA - how to make low cytotoxic and highly efficient PEI gene transfection non-viral vectors with a controllable chain length and structure?
R. Deng (2009)
10.1016/j.cbpa.2010.02.016
Applications of synthetic carbohydrates to chemical biology.
B. Lepenies (2010)
10.1007/s11051-015-3118-y
Targeting and molecular imaging of HepG2 cells using surface-functionalized gold nanoparticles
Pierson Rathinaraj (2015)
10.1038/SJ.NEO.7900003
The apoptosome: heart and soul of the cell death machine.
A. Chinnaiyan (1999)
10.1016/0169-409X(94)90003-5
Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes
M. Monsigny (1994)
10.1021/BI00164A020
Isolation and characterization of human heparin.
R. Linhardt (1992)
10.1021/BM015560K
Mannose functionalization of a sixth generation dendrimer.
E. Woller (2001)
10.1021/am500761x
Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma.
H. Liu (2014)
10.1038/nrc3982
Glycosylation in cancer: mechanisms and clinical implications
S. Pinho (2015)
10.1039/c5cs00092k
Carbohydrate nanocarriers in biomedical applications: functionalization and construction.
Biao Kang (2015)
10.4155/tde.13.6
Receptor-based targeting of therapeutics.
N. K. Mehra (2013)
10.1146/ANNUREV.BIOENG.9.060906.151959
The structure and function of the endothelial glycocalyx layer.
S. Weinbaum (2007)
10.1152/AJPLEGACY.1916.41.2.250
THE THROMBOPLASTIC ACTION OF CEPHALIN
J. Mclean (1916)
10.1158/1078-0432.CCR-04-2626
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
G. J. Kelloff (2005)
10.1155/2011/727241
Targeted Liposomal Drug Delivery to Monocytes and Macrophages
C. Kelly (2011)
10.1038/NCHEMBIO.2007.25
Robust immune responses elicited by a fully synthetic three-component vaccine.
S. Ingale (2007)
10.1016/S0959-440X(02)00365-2
Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes.
R. Kannagi (2002)
10.1039/9781849730891-00152
Bioorthogonal chemical reporter methodology for visualization, isolation and analysis of glycoconjugates.
Geert-Jan Boons (2010)
10.1164/AJRCCM.162.1.9712142
The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy.
K. Kerr (2000)
10.1111/j.1349-7006.2010.01587.x
Targeted delivery of oligomannose‐coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer
Makoto Matsui (2010)
10.1080/10717540902989738
Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer’s patches
Pongthep Pukanud (2009)
10.1002/mrm.10723
MRI detection of early endothelial activation in brain inflammation
N. Sibson (2004)
10.1016/J.JCIS.2007.09.065
Hepatic-targeting microcapsules construction by self-assembly of bioactive galactose-branched polyelectrolyte for controlled drug release system.
F. Zhang (2008)
10.1016/S0008-6215(00)84141-5
Synthesis of some cluster glycosides suitable for attachment to proteins or solid matrices
C. L. Yuan (1978)
10.1016/J.VACCINE.2007.01.065
Vaccines in the era of genomics: the pneumococcal challenge.
M. Barocchi (2007)
10.1126/science.1213256
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
R. Pejchal (2011)
10.1002/(SICI)1521-3765(20000417)6:8<1416::AID-CHEM1416>3.0.CO;2-O
Synthesis of high-mannose type neoglycolipids: active targeting of liposomes to macrophages in gene therapy.
A. Dueffels (2000)
10.1016/j.jconrel.2007.05.018
Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine
Xianfeng Zhou (2007)
10.1002/marc.201200055
The glycopolymer code: synthesis of glycopolymers and multivalent carbohydrate-lectin interactions.
C. R. Becer (2012)
10.1084/jem.20121827
Neutralizing antibodies to HIV-1 induced by immunization
L. E. McCoy (2013)
10.1016/j.nano.2010.10.010
Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison.
P. Kesharwani (2011)
10.1016/j.ejps.2010.04.004
Lactosaminated human albumin, a hepatotropic carrier of drugs.
L. Fiume (2010)
10.1021/cb900216e
Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation.
S. Sattin (2010)
10.1016/J.JCONREL.2007.10.011
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
Wassana Wijagkanalan (2008)
10.1021/ol901084k
Reductive addition of the benzenethiyl radical to alkynes by amine-mediated single electron transfer reaction to diphenyl disulfide.
Tsuyoshi Taniguchi (2009)
10.1038/nrg2006
Strategies for silencing human disease using RNA interference
D. Kim (2007)
10.1073/pnas.1217537110
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
J. Julien (2013)
10.1016/S1567-5769(02)00271-0
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.
H. Maeda (2003)
10.1021/JM030176M
2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.
R. Linhardt (2003)
10.1016/J.ADDR.2003.10.030
Lectin-mediated drug targeting: history and applications.
C. Bies (2004)
10.1016/j.addr.2013.11.009
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
N. Bertrand (2014)
10.1093/GLYCOB/3.2.97
Biological roles of oligosaccharides: all of the theories are correct
A. Varki (1993)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
10.1016/J.BIOMATERIALS.2007.04.004
Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.
Payal Agrawal (2007)
10.1021/JA0511974
Dendrimer-like PEO glycopolymers exhibit anti-inflammatory properties.
S. Rele (2005)
10.1039/c2cc31845h
Imaging beyond the proteome.
Pamela V Chang (2012)
10.2174/138161209789649547
Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery.
Wangyang Yu (2009)
10.1016/j.biomaterials.2014.01.065
A mannosylated cell-penetrating peptide-graft-polyethylenimine as a gene delivery vector.
Ying Hu (2014)
10.1002/ejoc.200900117
Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors.
M. Weïwer (2009)
10.1007/s00262-008-0537-y
Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes
I. Bettahi (2008)
10.1002/anie.200802036
New principles for glycoside-bond formation.
X. Zhu (2009)
10.1016/j.biomaterials.2014.06.012
Dextran-based fluorescent nanoprobes for sentinel lymph node mapping.
T. Dai (2014)
10.1016/S0169-409X(98)00040-4
Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.
Ponchel (1998)
10.1021/cb2004466
Modifications of glycans: biological significance and therapeutic opportunities.
Saddam M Muthana (2012)
10.1021/JA307501E
In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages.
Corwin M. Nycholat (2012)
10.1039/c0np00055h
Natural glycoconjugates with antitumor activity.
B. La Ferla (2011)
10.1002/cbic.200900294
Multivalent Manno‐Glyconanoparticles Inhibit DC‐SIGN‐Mediated HIV‐1 Trans‐Infection of Human T Cells
O. Martínez-Ávila (2009)
10.3389/fimmu.2013.00451
Analytical Tools for the Study of Cellular Glycosylation in the Immune System
Y. van Kooyk (2013)
10.1517/17425247.5.6.703
Mannose-targeted systems for the delivery of therapeutics
J. M. Irache (2008)
10.1158/0008-5472.CAN-06-0470
A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle.
Y. Ikehara (2006)
10.1002/jgm.470
In situ single cell observation by fluorescence resonance energy transfer reveals fast intra‐cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine
K. Itaka (2004)
10.1126/SCIENCE.291.5512.2364
Intracellular functions of N-linked glycans.
A. Helenius (2001)
10.1093/glycob/cwn128
Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages.
H. Takagi (2009)
10.1093/GLYCOB/CWG090
Glycosidase inhibitors: update and perspectives on practical use.
N. Asano (2003)
10.1016/J.POLYMER.2007.10.021
Poly(amidoamine), polypropylenimine, and related dendrimers and dendrons possessing different 1 → 2 branching motifs : An overview of the divergent procedures
G. Newkome (2008)
10.1002/ijc.24914
Tumor‐targeted intracellular delivery of anticancer drugs through the mannose‐6‐phosphate/insulin‐like growth factor II receptor
J. Prakash (2010)
10.1002/cbic.200300753
Chemical Biology of the Sugar Code
H. Gabius (2004)
10.1016/j.cell.2011.02.013
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)
10.2217/nnm.13.118
Current trends in the use of liposomes for tumor targeting.
Pranali P. Deshpande (2013)
10.1007/s10555-012-9359-7
Regulation of the metastatic cell phenotype by sialylated glycans
M. J. Schultz (2012)
10.1080/10611860600825159
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
Palanirajan Vijayaraj Kumar (2006)
10.1016/j.ejpb.2009.04.009
Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination.
V. Fiévez (2009)
10.1084/JEM.26.4.477
THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH
A. R. Dochez (1917)
10.1002/anie.201506112
Sugar–Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines
Giuseppe Stefanetti (2015)
10.1242/jcs.1988.Supplement_9.1
Plasma membrane receptors of the mononuclear phagocyte system
S. Gordon (1988)
10.1038/nature05757
Expanding the diversity of chemical protein modification allows post-translational mimicry
S. V. Kasteren (2007)
10.1016/J.JCONREL.2004.01.006
Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines.
P. Arbós (2004)
10.1084/JEM.52.4.573
CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE
Thomas Francis (1930)
10.4161/hv.34300
Moving a Carbohydrate Mimetic Peptide into the clinic
I. Makhoul (2015)
10.1021/JO9816461
Controlled Site-Selective Glycosylation of Proteins by a Combined Site-Directed Mutagenesis and Chemical Modification Approach
B. Davis (1998)
10.1371/journal.pone.0039545
Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach
M. Yoshida (2012)
10.1073/pnas.1002717107
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
K. Doores (2010)
10.1073/pnas.1121318109
A sulfated carbohydrate epitope inhibits axon regeneration after injury
J. Brown (2012)
10.1148/RADIOLOGY.214.2.R00FE19568
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
A. Moore (2000)
10.1016/j.ejps.2007.12.006
Radiolabeling, pharmacoscintigraphic evaluation and antiretroviral efficacy of stavudine loaded 99mTc labeled galactosylated liposomes.
M. Garg (2008)
10.1073/PNAS.89.23.11332
Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector.
T. Ohashi (1992)
10.1016/j.biomaterials.2012.07.022
PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes.
Landon W. Locke (2012)
10.1039/C4RA08681C
Liposomes containing mannose-6-phosphate-cholesteryl conjugates for lysosome-specific delivery
Emanuela Crucianelli (2014)
10.1016/j.biomaterials.2018.01.017
Galactosylated iodine-based small molecule I.V. CT contrast agent for bile duct imaging.
Yeonjin Jung (2018)
10.1016/S0304-4165(99)00165-8
On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database.
R. Apweiler (1999)
10.1208/s12249-010-9450-8
Sustained Liver Targeting and Improved Antiproliferative Effect of Doxorubicin Liposomes Modified with Galactosylated Lipid and PEG-Lipid
S. Wang (2010)
10.1016/j.cbpa.2010.09.020
Chemoenzymatic methods for site-specific protein modification.
David Rabuka (2010)
10.1016/J.IMLET.2005.04.002
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
S. Jain (2005)
10.1111/j.1365-2567.2006.02506.x
Mannan‐mediated gene delivery for cancer immunotherapy
C. Tang (2007)
10.1016/j.cell.2009.12.008
Metabolism, Cell Surface Organization, and Disease
J. Dennis (2009)
10.1002/chem.200800700
Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins.
A. Imberty (2008)
10.1021/cr078291i
Glycoprotein synthesis: an update.
David P. Gamblin (2009)
10.1016/j.cell.2006.08.019
Glycosylation in Cellular Mechanisms of Health and Disease
K. Ohtsubo (2006)
10.1021/jo201125x
Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
Jennifer D Diot (2011)
10.1002/chem.201202629
Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.
Brendan L Wilkinson (2012)
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
T. Gilewski (2000)
10.3987/COM-08-S(D)82
Synthesis of Human Cancer Associated Globo-H (MBr1) Glycosylamino Acid: Some Mechanistic and Conformational Reinvestigations.
J. Zhu (2009)
10.1002/ANIE.199316713
The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics
C. A. A. V. Boeckel (1993)
10.1038/sj.gt.3301089
Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes
S. Kawakami (2000)
10.1007/978-3-642-23056-1
Heparin - A Century of Progress
R. Lever (2012)
10.1021/cr0782426
Molecular imaging with PET.
S. Ametamey (2008)
10.3109/10611860108998770
Pharmacokinetic Analysis of Lectin-dependent Biodistribution of Fucosylated Bovine Serum Albumin: A Possible Carrier for Kupffer Cells
P. Opanasopit (2001)
10.1021/JO00027A021
Highly selective thioselenation of olefins using disulfide-diselenide mixed system
A. Ogawa (1992)
10.4161/hv.7.0.14578
Glycan mediated immune responses to tumor cells
Anastas Pashov (2011)
10.1016/j.chembiol.2008.07.016
Mass spectrometry and the emerging field of glycomics.
J. Zaia (2008)
10.1016/j.jconrel.2015.06.028
Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.
O. V. Markov (2015)
10.1002/mrm.20403
Magnetic resonance imaging of inflammation with a specific selectin‐targeted contrast agent
S. Boutry (2005)
10.1016/J.EJPB.2006.12.019
Reduced hepatic toxicity, enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomes.
M. Garg (2007)
10.1016/S0304-4165(99)00167-1
Glycoprotein glycosylation and cancer progression.
J. Dennis (1999)
10.1371/journal.pone.0039039
Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169
Weihsu C Chen (2012)
10.1073/pnas.1222649110
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer
Y. Huang (2013)
10.1038/NBT0298-181
Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes
G. Dietrich (1998)
10.1016/j.chembiol.2013.09.010
Glycotherapy: new advances inspire a reemergence of glycans in medicine.
Jason E. Hudak (2014)
10.1016/j.jconrel.2010.09.003
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Ashay Jain (2010)
10.1073/pnas.0806787106
Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease
S. V. van Kasteren (2009)
10.1038/nrc1251
Mucins in cancer: protection and control of the cell surface
M. Hollingsworth (2004)
10.1146/ANNUREV.BI.64.070195.000553
Selectin-carbohydrate interactions and the initiation of the inflammatory response.
L. Lasky (1995)
10.1002/jgm.1162
Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice
Y. Kuramoto (2008)
10.1016/J.CARBPOL.2006.06.017
Synthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptor
W. Lin (2007)
10.1016/j.conb.2006.09.004
The role of extracellular matrix in CNS regeneration
S. A. Busch (2007)
Chemical glycobiology : Carbohydrates and glycobiology
C. Bertozzi (2001)
10.1021/ja405990z
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines.
Baptiste Aussedat (2013)
10.1021/MA5020462
Facile Synthesis of Fluorescent Latex Nanoparticles with Selective Binding Properties Using Amphiphilic Glycosylated Polypeptide Surfactants
Jaco Jacobs (2014)
10.1038/nbt1159
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
R. Weissleder (2005)
10.1245/s10434-006-9194-6
Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping
E. Tanaka (2006)
10.1002/anie.201002313
The Tn Antigen—Structural Simplicity and Biological Complexity
T. Ju (2011)
10.1016/j.biomaterials.2012.02.060
Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes.
Xinglu Huang (2012)
10.1158/1535-7163.MCT-05-0540
Mannosylated chitosan nanoparticle–based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells
T. Kim (2006)
10.1038/sj.gt.3301140
Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
M. Nishikawa (2000)
10.1021/mp200313e
Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase.
O. Abián (2011)
10.1039/c3cs60097a
Glycopolymer probes of signal transduction.
L. Kiessling (2013)
10.1097/00000658-199409000-00015
Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
A. Giuliano (1994)
10.1084/JEM.38.1.73
THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS
M. Heidelberger (1925)
10.1093/GLYCOB/12.4.43R
Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.
R. Spiro (2002)
10.1016/J.BBAGEN.2006.12.007
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
10.1021/CR000418F
The cluster glycoside effect.
J. J. Lundquist (2002)
10.1038/nri1182
DC-SIGN: escape mechanism for pathogens
Y. Kooyk (2003)
10.1002/cmdc.200800380
Glycopeptide Dendrimers with High Affinity for the Fucose‐Binding Lectin LecB from Pseudomonas aeruginosa
E. Kolomiets (2009)
10.1016/J.BIOMATERIALS.2005.10.027
Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Hsiang-Fa Liang (2006)
10.1021/bc500004c
Glycan-Functionalized Fluorescent Chitin Nanocrystals for Biorecognition Applications
J. Zhou (2014)
10.1002/PPSC.201600113
Facile Synthesis of Lactobionic Acid‐Targeted Iron Oxide Nanoparticles with Ultrahigh Relaxivity for Targeted MR Imaging of an Orthotopic Model of Human Hepatocellular Carcinoma
Y. Hu (2017)
10.1038/nri1375
Adhesion mechanisms regulating the migration of monocytes
B. Imhof (2004)
10.4049/jimmunol.0803141
A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection1
A. Phalipon (2009)
10.1038/ni.f.203
Protein-glycan interactions in the control of innate and adaptive immune responses
Y. Kooyk (2008)
10.1021/ja4029582
Nanomolar E-selectin antagonists with prolonged half-lives by a fragment-based approach.
J. Egger (2013)
10.1182/blood-2009-12-260513
GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice.
Jungshan Chang (2010)
10.1046/j.1365-3148.2001.00321.x
The ABO blood group system: historical background
W. Watkins (2001)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I4.10
Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.
M. Nahar (2006)
10.1021/cr900341m
Dendrimers derived from 1 → 3 branching motifs.
G. Newkome (2010)
10.1128/IAI.01093-09
Synthetic β-(1→6)-Linked N-Acetylated and Nonacetylated Oligoglucosamines Used To Produce Conjugate Vaccines for Bacterial Pathogens
M. Gening (2009)
10.1016/J.IJPHARM.2005.02.027
Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety.
Y. Jeong (2005)
10.2147/IJN.S25182
Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications
R. Ranganathan (2012)
10.1038/ncb0908-1015
A unified vision of the building blocks of life
J. Marth (2008)
10.1615/CRITREVTHERDRUGCARRIERSYST.V14.I2.20
Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations.
R. Mahato (1997)
10.1126/SCIENCE.276.5311.428
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin.
F. Platt (1997)
10.1038/23481
Heparin is essential for the storage of specific granule proteases in mast cells
D. Humphries (1999)
10.1016/J.JCONREL.2006.12.019
Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Kosuke Shigeta (2007)
10.1016/j.imbio.2008.11.004
Influence of the mannose receptor in host immune responses.
U. Gazi (2009)
10.1021/cb9002514
Regulation of intracellular signaling by extracellular glycan remodeling.
Randy B Parker (2010)
10.1371/journal.pone.0021499
6-Sulphated Chondroitins Have a Positive Influence on Axonal Regeneration
R. Lin (2011)
10.1016/S0959-8049(00)00029-0
Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model.
E. Vodovozova (2000)
10.1016/J.IJPHARM.2007.09.024
Ligand based dendritic systems for tumor targeting.
A. Agarwal (2008)
10.1016/J.JCONREL.2004.10.024
Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
Xue-qing Zhang (2005)
10.1007/s10856-009-3741-1
Immobilization of lactobionic acid on the surface of cadmium sulfide nanoparticles and their interaction with hepatocytes
K. M. Kamruzzaman Selim (2009)
10.1021/CR040660C
Synthetic routes to thiooligosaccharides and thioglycopeptides.
K. Pachamuthu (2006)
10.1038/84635
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
S. Stacker (2001)
10.2174/156802608783378864
Recent developments in synthetic oligosaccharide-based bacterial vaccines.
V. Pozsgay (2008)
10.1002/ANIE.200352975
Glyco-SeS: selenenylsulfide-mediated protein glycoconjugation--a new strategy in post-translational modification.
David P. Gamblin (2004)
10.1038/nbt.2373
Discovering ligand-receptor interactions
Sarah A Slavoff (2012)
10.1016/J.EJPB.2005.07.004
Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
Shao-Ning Wang (2006)
10.3181/00379727-55-14461
Streptomycin, a Substance Exhibiting Antibiotic Activity Against Gram-Positive and Gram-Negative Bacteria.∗†
A. Schatz (2005)
10.4049/jimmunol.170.3.1462
Differential Expression of the Murine Mannose-Binding Lectins A and C in Lymphoid and Nonlymphoid Organs and Tissues 1
S. Wagner (2003)
10.1021/JM9704917
Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).
T. P. Kogan (1998)
10.1038/onc.2008.310
Lysosomal membrane permeabilization in cell death
P. Boya (2008)
10.1016/j.ijpharm.2008.04.029
Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles.
Guifang Huang (2008)
10.1128/JVI.78.22.12665-12667.2004
Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium
M. Matrosovich (2004)
Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine.
A. Stewart (1996)
10.1073/pnas.0807837105
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
J. Joyce (2008)
10.1002/anie.201205831
Click and pick: identification of sialoside analogues for siglec-based cell targeting.
Cory D. Rillahan (2012)
10.1073/pnas.0804919105
In vivo supramolecular templating enhances the activity of multivalent ligands: A potential therapeutic against the Escherichia coli O157 AB5 toxins
P. I. Kitov (2008)
10.1038/ncb1079
An NDPase links ADAM protease glycosylation with organ morphogenesis in C. elegans
K. Nishiwaki (2004)
10.1021/OL070119D
Neoglycopeptide dendrimer libraries as a source of lectin binding ligands.
E. Kolomiets (2007)
10.1182/BLOOD.V93.9.2807.409K08_2807_2816
A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease.
B. Friedman (1999)
10.1016/j.biomaterials.2009.12.022
Synthesis of a family of amphiphilic glycopolymers via controlled ring-opening polymerization of functionalized cyclic carbonates and their application in drug delivery.
Fabian Suriano (2010)
10.1126/science.1207478
Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins
Y. Xu (2011)
10.1586/14760584.4.5.677
Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities
O. Ouerfelli (2005)
10.1093/GLYCOB/3.3.271
Mode of interaction between platelet factor 4 and heparin.
M. Maccarana (1993)
10.1021/jm901265h
Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors.
S. Ferreira (2010)
10.3727/000000007783980837
Antitumor activity of mannan-methotrexate conjugate in vitro and in vivo.
Renata Budzynska (2007)
10.1016/j.bbamcr.2008.09.008
Lysosomal involvement in cell death and cancer.
T. Kirkegaard (2009)
10.1016/J.CARRES.2006.11.018
Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines.
R. Ojeda (2007)
10.1039/C4TB01542H
Targeted CT imaging of human hepatocellular carcinoma using low-generation dendrimer-entrapped gold nanoparticles modified with lactobionic acid.
Yiyun Cao (2015)
Possible roles of tumor-associated carbohydrate antigens.
M. Fukuda (1996)
10.1016/j.tips.2009.02.005
Siglecs as targets for therapy in immune-cell-mediated disease.
M. O'Reilly (2009)
10.1161/01.RES.44.1.127
The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane
M. Reivich (1979)
10.1039/C1SC00185J
Methods for converting cysteine to dehydroalanine on peptides and proteins
Justin M. Chalker (2011)
10.1021/JA01624A062
Immunochemical Studies on Blood Groups. XVII. Structural Units Involved in Blood Group A and B Specificity1
E. Kabat (1955)
10.1002/anie.200902620
Glycosphingolipids--nature, function, and pharmacological modulation.
T. Wennekes (2009)
10.1073/pnas.0712326105
Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
Sheng-Kai Wang (2008)
10.1021/bc100397b
Synthesis and immunogenicity of a glycopolymer conjugate.
T. Lipiński (2011)
10.1021/OL0270935
Chemoselectively template-assembled glycoconjugates as mimics for multivalent presentation of carbohydrates.
O. Renaudet (2003)
10.1016/j.tibs.2010.04.005
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
C. Slawson (2010)
10.1039/b907931a
The repertoire of glycan determinants in the human glycome.
R. Cummings (2009)
10.1128/JVI.00293-08
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120
Rena D. Astronomo (2008)
10.1016/J.IJPHARM.2005.01.026
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting.
D. Bhadra (2005)
10.1080/10409230701751611
Glycan Antagonists and Inhibitors: A Fount for Drug Discovery
J. Brown (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar